APA (7th ed.) Citation

Sävendahl, L., Battelino, T., Højby Rasmussen, M., Brod, M., Saenger, P., & Horikawa, R. (2022). Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3. The journal of clinical endocrinology and metabolism, 107(5), 1357-1367. https://doi.org/10.1210/clinem/dgab928

Chicago Style (17th ed.) Citation

Sävendahl, Lars, Tadej Battelino, Michael Højby Rasmussen, Meryl Brod, Paul Saenger, and Reiko Horikawa. "Effective GH Replacement With Once-weekly Somapacitan Vs Daily GH in Children with GHD: 3-year Results From REAL 3." The Journal of Clinical Endocrinology and Metabolism 107, no. 5 (2022): 1357-1367. https://doi.org/10.1210/clinem/dgab928.

MLA (9th ed.) Citation

Sävendahl, Lars, et al. "Effective GH Replacement With Once-weekly Somapacitan Vs Daily GH in Children with GHD: 3-year Results From REAL 3." The Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 5, 2022, pp. 1357-1367, https://doi.org/10.1210/clinem/dgab928.